Company profile
T2S Group Holding SA
T2S Group Holding SA is a Morocco-based holding company operating in the medical technology sector. The Company is organised into four operating subsidiaries: Techniques Science Santé, IM Alliance, Cyclopharma, and Binarios. Techniques Science Santé and IM Alliance distribute and maintain medical imaging, oncology, cardiology, and in vitro diagnostic equipment; Cyclopharma manufactures radiopharmaceutical contrast products; and Binarios develops hospital imaging and information software (PACS, RIS, HIS, LIS). Established in 1992 and headquartered in Casablanca, Morocco, the group serves public and private healthcare providers in Morocco and more than twenty other African countries, principally Francophone West and Central Africa. T2S Group Holding is listed on the Bourse de Casablanca under ticker T2S following its July 2026 initial public offering.
- Sector
- Healthcare / Pharmaceuticals, Digital Health Platforms, Medical Equipment
- Markets
- Morocco
- Founded
- 1992
- Ownership
- Public
- Stage
- Large Enterprise
- Capital raised
- $117.5m
- Post-money valuation
- $523.5m
- Employees
- 500+
- Business model
- B2B Retail/E-commerce, Consulting/Advisory, Licensing, Manufacturing
Products and services
VisionPACS, VisionRIS, VisionHIS, VisionLIS, Mammotome Elite, GLUSCAN & Cyclopharma Radiopharmaceuticals
Transactions
| Date | Transaction | Type | Value | Market |
|---|---|---|---|---|
| 27 Jul 2026 | Helios Investment Partners exits T2S Group on the Casablanca Stock Exchange for MAD 1.1 billion | Private Equity | $117.5m | Morocco |
Source: Partner Researchers.